Purpose: the objective of the present study was to evaluate the effect of BM-MSCs on irradiated submandibular salivary glands in mice and to determine at which stage post-irradiation the cells should be transplanted. Materials and methods: 58 adult male mice were used, 10 for preparation of PKH-26-labeled BM-MSCs and the remaining 48 mice were divided into: control group (GӀ) consisted of 6 mice without radiation and experimental groups consisted of 42 mice irradiated with a single dose of 15Gy. They were randomly divided into three groups: GӀӀ (+ve control): 18 irradiated not treated mice and two treated groups each consisted of 12 irradiated mice and treated with intraglandular injection of labeled BM-MSCs, 24 hours (GӀӀӀ) and at day 11 (GΙV) post-radiation. Animals were sacrificed at day 6, day 30 and day 90 post-radiation. The submandibular glands were collected, one gland was routinely prepared for histological examination using H&E staining and the other was prepared for immunohistochemical study using immunofluorescence staining with anti-α-amylase 1 antibody. Results:
INTRODUCTION
Salivary glands are responsible for secretion of approximately one and half liter of saliva daily. Saliva plays a pivotal role in moistening the oropharyngeal mucosa which is essential for speech, taste sensation, mastication, preparing the bolus of food and deglutition (1) .
In addition, saliva plays an essential role in the maintenance of teeth integrity and has several constituents with digestive, protective and antimicrobial effects (2) . Saliva also contains growth factors e.g. epidermal growth factor which enhances ulcers healing (2, 3) . For these reasons, any dysfunction or cessation to saliva production greatly affects oral and general health and comfort (1, 4) .
Moreover, several systemic conditions can produce hyposalivation and xerostomia including; aging, uncontrolled diabetes mellitus, hypertension, medications (5) . However, one of the most severe conditions that cause severe xerostomia is radiotherapy for head and neck cancer (6) .
According to statistics that were done in 2016; squamous cell carcinoma in head and neck region is the fifth most common malignancy all over the world (7) . Most head and neck cancer are routinely treated with radiotherapy, either alone or together with chemotherapy, surgery, or both (8) . Before the introduction of updated radiotherapy modalities, more than 80% of survivors of patients receiving radiotherapy suffered from dry mouth syndrome which is irreversible and a life-long problem (9) (10) (11) . Although the use of the advanced modalities, radiotherapy still causes xerostomia in high percentage (12) (13) (14) , approximately 40% (12) .
Although salivary acinar cells are highly differentiated slowly proliferating cells, they are highly radiosensitive (15, 16) . The serous acini are affected by radiation more quickly than the mucous acini and the ducts (15) (16) (17) . Two main phases of salivary gland response to radiation are described: early and late. The early phase is noticed up to day 10 post-radiation (18) with the observed morphological changes are maximal at day 6 post-radiation (18) (19) (20) . Then, signs of tissue regeneration start to appear at day 10 post-radiation. At day 40 post-radiation, the gland architecture is greatly improved. The second, late phase is observed at day 90 post-radiation with severe glandular destruction, marked decrease in acinar cells' number, edema and disseminated mononuclear infiltration (18) .
On the other hand, several axes have been performed for management of radiation-induced xerostomia including: preventive measures and treatment of radiation induced xerostomia. The preventive measures aiming for salivary gland protection using intensity modulated radiotherapy (IMRT), adaptive modulated therapy (AMT), salivary gland transfer and radioprotectors (6) .
Moreover, treatment of radiation induced xerostomia includes palliative treatments, salivary gland stimulation using sialogogues or acupuncture, and regeneration of the damaged salivary glands. Salivary gland regeneration can be achieved using alternative treatment approaches including growth factors, gene therapy, tissue engineering, or stem cell-based therapy (6, 21, 22) .
Mesenchymal stem cells (MSCs) are multipotent stem cells. The first known source for them was bone marrow (BM-MSCs). Today, there are several sources for their isolation including the adipose tissue, umbilical cord blood, umbilical cord membrane, placenta, dental pulp and periodontal ligament (23) (24) (25) .
Furthermore, BM-MSCs like other MSCs can act by two mechanisms: their differentiation potential and secretion of soluble factors. MSCs have the potential to differentiate into cells of the three germ layers as reported by several in vitro and in vivo studies (23) (24) (25) . In addition, they secrete many soluble factors which have several paracrine effects on the nearby cells which enhance tissue repair. Their secreted factors can also strongly regulate the immune responses by affecting all the cells of the immune system to produce an anti-inflammatory phenotype (23) . Stem Cells and Their Potential Effect on Irradiated Submandibular Salivary Glands (33) Moreover, MSCs are now the most common type of stem cells applied clinically. Till now, MSCs from different sources have been used clinically to treat several degenerative and immune-related diseases with high effectiveness and safety (23) (24) (25) .
Since radiation-induced damage to salivary stem/progenitor cells is considered as the cause for the resultant xerostomia, stem cells transplantation can greatly enhance salivary gland regeneration (26) . It has been demonstrated that direct intraglandular transplantation of BM-MSCs, 24 hours post-radiation, can regenerate the damaged gland and restore its function by differentiation into saliva producing cells as well as secreting paracrine factors (27) .
MATERIAL AND METHODS

Animals:
Fifty eight adult male mice (weighing 18-25 g, 8-12 weeks old) were used in this study. Animal handling followed the rules and regulations of the animal experimental studies that were approved by ethical committee including their facilities, diet and method of scarification.
Ten mice were used for BM-MSCs preparation and the remaining forty eight mice were randomly divided into: A control group (group Ӏ), consisted of 6 non irradiated mice and experimental groups, consisted of 42 irradiated mice. They were randomly divided, after radiation, into three groups, including; group ӀӀ (+ve control): consisted of 18 irradiated non treated mice, group ӀӀӀ: consisted of 12 irradiated mice, treated with intraglandular injection of labeled BM-MSCs into their submandibular salivary glands, 24 hours post-radiation and group ΙV: consisted of 12 irradiated mice, treated with intraglandular injection of labeled BM-MSCs into their submandibular salivary glands, at day 11 postradiation.
Isolation and expansion of mice BM-MSCs:
The tibias and femurs of the mice were collected, bone marrow samples were gathered from them and BM-MSCs were isolated and then identified us-ing flow cytometric and phenotyping analysis (28, 29) . BM-MSCs were then labeled using PKH-26 Red Fluorescent Cell Linker Kit (Sigma Aldrich, St. Louis, MO, USA).
Irradiation process:
The adult male mice were generally anaesthetized with thiopental sodium (Egyptian Pharmaceutical International Company (EPICO), was purchased from local market), ultra short acting barbiturate, (60mg/Kg) injected intra-peritoneally (i.p.) (30, 31) . Then, the mice head and neck region received 15 Gray (15Gy) gamma radiation, using lead shield for the rest of the body (11, 27, 32) .
Intraglandular transplantation of BM-MSCs:
24 hours post-radiation (27) , the mice of both group II and group III were generally anaesthetized with i.p. injection of thiopental sodium, (60mg/Kg) (30, 31) . A vertical incision of the neck was made and the skin was retracted gently to expose submandibular salivary glands. Then, each submandibular gland of the mice of group III was directly injected with 1x10 5 PKH-26 labeled BM-MSCs in 50 µӏ of PBS, while the submandibular glands of the mice of group II were injected with 50 µӏ of PBS alone (27, 33) .
After injection, the surgical wound was sutured using coated VICRYL® braided suture (5-0) (A synthetic, absorbable, surgical suture, was purchased from local market), then covered with Penicillin G powder antibiotic. At day 11 post-radiation (34) , the mice of group IV were anaesthetized and injected with BM-MSCs by the same way that was mentioned before.
Specimens collection:
At day 6 post-radiation (D6), 6 mice from group II were anaesthetized then sacrificed separately by cervical dislocation. A vertical incision of the neck was made and the skin was retracted gently to expose submandibular salivary glands, then the glands were dissected. At the same way, the glands of 6 mice from each group were collected at both (34) Seham I. Hallool, et al.
ADJ-for Grils, Vol. 7, No. 1 day 30 (D30) and day 90 (D90) post-radiation. For each sacrificed mouse, one gland was prepared and histologically examined, while the other gland was prepared for immunohistochemical study using immunofluorescence staining.
Specimens preparation:
a. Preparation of the specimens for histological examination:
The specimens were routinely fixed, dehydrated, cleared and paraffin wax embedded. Then 4 micron thickness sections were cut, stained by H& E stain and examined by light microscope at different magnifications.
b. Preparation of the specimens for immunohistochemical study using immuonofluorescence staining to detect α-amylase 1 secretion:
Paraffin tissue sections were deparaffinized and rehydrated then antigen retrieval was performed. The sections then were incubated with blocking buffer for 1 h, then incubated with the primary antibody, rabbit polyclonal anti-alpha amylase 1 (AMY1A) (were purchased from (Chongqing Biospes Co., Ltd, China). Detection of bound antibodies was done by Alexa Fluor secondary antibodies (were purchased from (Abcam Cambridge, MA, USA). Nuclei were stained with DAPI (4,6-diamino-2-phenyllindole), was purchased from (Abcam Cambridge, MA, USA). Slides were mounted and examined using Nikon fluorescence microscope under blue, green and red channels. Fluorometric analysis then was performed (35, 36) .
Statistical analysis:
Computerized image analysis was used to assess the percentage of α-amylase1 secretion positive surface areas within the immunofluorescent stained sections of all groups. The positive surface areas appeared as green areas. The results were then collected, tabulated and statistically analyzed.
Statistical analysis was performed using a commercially available software program (SPSS 19; SPSS, Chicago, IL, USA). As data was parametric, ANOVA test was used for evaluation of values, followed by Tukey's post hoc test.
RESULTS
A. Histological results:
Examination of H&E stained sections from submandibular salivary glands of group ΙΙ at different time intervals (D6, D30 and D90) post-radiation revealed that the most severely destructed glands appeared at D90 with the most severe histopathologic changes, acinar atrophy and shrinkage and extremely wide interlobular and inter acinar spaces; compared with the other intervals, especially D30 which showed the best gland architecture with the least histopathologic changes. Fig. (1-A) Comparing H&E stained sections from submandibular salivary glands of group ΙΙ, group ΙΙΙ and group ΙV at D90 post-radiation revealed that group ΙΙΙ showed relatively normal gland architecture with compact acinar arrangement, normal inter acinar and interlobular spaces, markedly the most preserved acinar and ductal architecture and cell lining and the most clearly apparent mitotic figures while the glands of group ΙΙ appeared markedly the most severely destructed. Fig. (1-B) 
B. Immunohistochemical results for detection of α-amylase 1 secretion (immuonofluorescence staining):
Fluorescence microscopic examination of immunofluorescent stained sections from the submandibular salivary glands of group II at different intervals (D6, D30, D90) post-radiation revealed +ve reaction of the tissues to α-amylase 1 secretion. The reaction was the highest at the 6th day post-radiation, but less than the reaction that was expressed in the control group. The least reaction was found at day 90 post-radiation. Fig. (2-A) Stem Cells and Their Potential Effect on Irradiated Submandibular Salivary Glands (35) Comparing the immunofluorescent stained sections from submandibular salivary glands of group ΙΙ, group ΙΙΙ and group ΙV at D90 post-radiation revealed that group II (GΙΙ D90) showed the least reaction to α-amylase 1 secretion, while it was the highest in group ΙΙΙ. Fig. (2-B) 
C. Statistical analysis:
The highest mean value of α-amylase 1 surface area was recorded in control group (GI), whereas the lowest mean value was recorded in group II (ir-radiated group) day 90 post-radiation (GII D90). ANOVA test revealed that the difference between all groups was extremely statistically significant. Tukey's post hoc test revealed that GI was significantly higher than all other groups, while GII D90 was significantly lower than all other groups. However, there was no significant difference between groups: GII D6, GIII D30, GIV D30 and GIII D90. Moreover, there was no significant difference between groups: GII D30, GIV D30 and GIV D90. 
DISCUSSION
The aim of this study was based on the recommendation of a previous study to perform further investigations to determine at which stage postradiation the BM-MSCs should be transplanted (27) . In this study, single intraglandular injection of BM-MSCs was done either 24 h post-radiation (27) or at day 11 post-radiation (34) . These chosen dates were selected to be either nearly at the beginning or at the end of the early phase of post-radiation gland reaction (18, 34) to assess whether the time of BM-MSCs transplantation could affect the gland regeneration.
In the foregoing study, day 6 was selected for specimens collection to confirm the early phase of radiation induced salivary glands damage which has been estimated to be maximal at day 6 postradiation (18) (19) (20) .
Moreover, day 30 was selected for specimen collection in accordance with previous studies (27, 34) , to study the intermediate phase of radiation induced damage of the salivary secretory tissue in which some tissue regeneration and attempts towards recovery were observed (6, 18) .
In addition, day 90 was selected in agreement with previous studies (8, 27) , to study the late phase of radiation induced damage of the salivary secretory tissue and to assess the beneficial effect of the injected BM-MSCs on the irreversibly damaged salivary gland tissue.
The histological results of the present study revealed that the submandibular glands of the irradiated non treated group (group ΙΙ) appeared most severely destructed at D90 compared with the other intervals, especially D30 which showed the best gland architecture with the least histopathologic changes. These findings were closely agreed with several previous studies (18, 27) .
Moreover, comparing H&E stained sections from the glands of group ΙΙ, group ΙΙΙ and group ΙV revealed that group ΙΙΙ showed the best gland architecture which appeared relatively normal with markedly the most preserved acinar and ductal architecture and cell lining and mild histopathologic changes compared with the other two groups, especially group ΙΙ. The glands of group ΙΙ appeared the most severely destructed. These foregoing observations revealed that intraglandular transplantation of BM-MSCs 24 h post-radiation greatly enhanced regeneration of irradiated salivary glands. These findings agreed with a previous study which concluded that intraglandular transplantation of BM-MSCs 24 h post-radiation provided regeneration of glandular tissues and gland function to 80-90 % of non-irradiated controls, at day 90 post-radiation. They reported that BM-MSCs exerted this effect through their paracrine actions and their potential to transdifferentiate into salivary epithelial cells (27) .
An interesting observation related to the time of BM-MSCs transplantation revealed that less improvement in the submandibular glands of mice in group IV than those in group III. These finding suggested that the early transplantation of BM-MSCs 24 h post-radiation, i.e. almost with the beginning of early phase of radiation damage, was more beneficial for tissue regeneration than the transplantation at day 11 post-radiation, i.e. after the end of the early phase. This could be explained as, the transplanted BM-MSCs 24 hours post-radiation with their powerful anti-inflammatory and immunomodulatory functions (23, 25) could able to decrease the inflammatory reaction that occur immediately post-radiation. This in turn could reduce the immune-mediated destruction of the parenchyma (20) , compared with the transplanted cells after the end of the early phase in which the inflammatory reaction has already established and produced destruction of the parenchyma.
On the other hand, immunohistochemical studying of specimens using immunofluorescence staining was performed in this study and the results were analyzed statistically to assess and compare the percentage of α-amylase 1 positive surface areas within the glands of mice of the different groups. This aimed to assess the effect of radiation and BM-MSCs transplantation on the gland function in accordance to other previous studies (27, 33, 34) .
The forgoing results revealed that the percentage of α-amylase 1 positive surface areas within the glands of mice of group II was significantly reduced at all time intervals (D 6, D 30 and D 90) post-radiation, compared with the control group. The glands of mice of group II at day 90 post-radiation showed the lowest value in all groups. These results were consistent with the reported histological results and were in agreement with findings reported by previous investigators (27, 34) .
The recorded immunohistochemical results and statistical data in this study confirmed the histological results since the percentage of α-amylase 1 positive surface areas within the glands of mice of both treated groups (group III and group ΙV) was significantly increased compared with group II at the different intervals, especially at day 90 post-radiation. However, group ΙV (irradiated and injected with BM-MSCs at day 11 post-radiation) showed less significant increase compared to group ΙΙΙ (irradiated and injected with BM-MSCs 24 h post-radiation). So, according to this protocol, the time of BM-MSCs transplantation should be considered as a main influencing factor.
CONCLUSIONS
From the previously mentioned results, the following could be concluded:
1. Intraglandular transplantation of BM-MSCs could successfully regenerate radiation-induced submandibular salivary gland damage and restore the gland function.
2. The early transplantation of BM-MSCs 24 hours post-radiation (i.e. almost with the beginning of early phase of radiation damage) was markedly more beneficial for tissue regeneration and restoration of glands function than the transplantation at day 11 post-radiation (i.e. after the end of the early phase).
